Edition:
United Kingdom

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

5,750JPY
20 Nov 2017
Change (% chg)

¥-60 (-1.03%)
Prev Close
¥5,810
Open
¥5,710
Day's High
¥5,770
Day's Low
¥5,630
Volume
241,900
Avg. Vol
151,026
52-wk High
¥6,970
52-wk Low
¥5,410

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- March 20 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.50 3.50 3.50 3.50

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-17 2 102,850.00 102,900.00 102,800.00 --
Year Ending Mar-18 2 100,450.00 100,700.00 100,200.00 108,500.00
Year Ending Mar-19 2 97,000.00 97,200.00 96,800.00 106,850.00
Earnings (per share)
Year Ending Mar-17 2 516.11 520.83 511.40 --
Year Ending Mar-18 2 481.95 490.20 473.70 574.08
Year Ending Mar-19 2 443.96 458.82 429.10 541.23

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 21,845.00 20,249.00 1,596.00 7.31
Quarter Ending Dec-12 24,290.00 23,282.00 1,008.00 4.15
Quarter Ending Sep-12 22,719.00 22,742.00 23.00 0.10
Quarter Ending Jun-12 21,400.00 20,781.00 619.00 2.89
Quarter Ending Dec-11 24,370.00 23,661.00 709.00 2.91

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-17 102,850.00 -- -- -- --
Year Ending Mar-18 100,450.00 100,450.00 100,450.00 100,450.00 108,500.00
Year Ending Mar-19 97,000.00 97,000.00 97,700.00 97,700.00 106,850.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-17 -- -- -- --
Year Ending Mar-18 0 0 0 0
Year Ending Mar-19 0 0 0 1
Earnings